Klinik und Poliklinik für Neurologie

Publikationen 1998/1999

Becher H, Tiemann K, Schlosser T, Pohl C, Nanda NC, Powers J, Lüderitz B. Improvement of endocardial border delineation using Tissue Harmonic Imaging. Echocardiogr J Cardiol. 1998;15:511-17.

Bendszus M, Urbach H, Ries F, Solymosi L. Outcome after local intra-arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT. Neuroradiology. 1998;40:54-8.

Block W, Karitzky J, Träber F, Pohl C, Keller E, Mundegar R, Lamerichs R, Rink H, Ries F, Schild H, Jerusalem F. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: Subgroup analysis and follow up measurements. Arch Neurol. 1998;55:931-6.

de Groote C, Wüllner U, Löschmann PA, Luiten PGM, Klockgether T. Functional characterization and expression of GABAB receptors in a rodent model of Parkinson's disease. Neuropharmacology. 1999;38:1683-9.

Evert BO, Wüllner U, Schulz JB, Weller M, Groscurth P, Trottier Y, Brice A, Klockgether T. High level expression of expanded full-length ataxin-3 in vitro causes cell death and formation of intranuclear inclusions in neuronal cells. Hum Mol Genet. 1999;8:1169-76.

Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G. Consensus statement on the diagnosis of multiple system atrophy. Clin Auton Res. 1998;8:359-62.

Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning G. Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst. 1998;74:189-92.

Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999;163:94-8.

Heneka MT, Feinstein DL, Galea E, Gleichmann M, Wüllner U, Klockgether T. Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase. J Neuroimmunol. 1999;100:156-68.

Heneka MT, Schmidlin A, Wiesinger H. Induction of argininosuccinate synthetase in rat brain glial cells after striatal microinjection of immunostimulants. J Cereb Blood Flow Metab. 1999;19:898-907.

Kastrup A, Hagendorff A, Dettmers C, Lüderitz B, Hartmann A. Hemodynamic sequelae of ventricular tachyarrhythmias on cerebral blood flow. Neurol Res. 1998;20:549-54.

Klisch J, Keller E, Brechtelsbauer D, Flacke S, Gass S, Schild RL, Hartmann A, Schild HH. Cerebral MRI in pre-eclampsia and eclampsia. Rofo-Fortschr Rontg. 1998;168:400-3.

Klockgether T, Evert B. Genes involved in hereditary ataxias. Trends Neurosci. 1998;21:413-8.

Lie AA, Schröder R, Blümcke I, Magin TM, Wiestler OD, Elger CE. Plectin in the human centralnervous system: predominant expression at pia/glia and endothelia/glia interfaces. Acta Neuropathol. 1998;96:215-21.

Magin TM, Schröder R, Leitgeb S, Wanninger F, Zatloukal K, Grund C, Melton DW. Lessons from keratin 18 knockout mice: Formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific K8-positive aggregates. J Cell Biol. 1998;140:1441-51.

Padberg F, Feneberg W, Schmidt S, Schwarz MJ, Korschenhausen D, Greenberg BD, Nolde T, Müller N, Trapmann H, König N, Möller HJ, Hampel H. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis. J Neuroimmunol. 1999;99:218-23.

Pohl C, Klockgether T, Greinacher A, Hanfland P, Harbrecht U. Neurological complications in heparin-induced thrombocytopenia. Lancet. 1999;353:1678-9.

Riemenschneider MJ, Büschges R, Wolter M, Reifenberger J, Boström J, Kraus JA, Schlegel U, Reifenberger G. Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res. 1999;59:6091-6.

Ries F, Tiemann K, Pohl C, Bauer C, Mundo M, Becher H. High resolution emboli detection and differentiation by characteristic postembolic spectral patterns. Stroke. 1998;29:668-72.

Roller A, Bähr O, Streffer J, Winter S, Heneka MT, Deininger M, Meyermann R, Naumann U, Gulbins E, Weller M. Selective potentiation of drug cytotoxicity by NSAID in human glioma cells: the role of COX-1 and MRP. Biochem Biophys Res Commun. 1999;259:600-5.

Rudnik-Schöneborn S, Nicholson GA, Morgan G, Röhrig D, Zerres K. Different patterns of obstetric complications in myotonic dystrophy in relation to the disease status of the fetus. Am J Med Genet. 1998;80:314-21.

Rudnik-Schöneborn S, Röhrig D, Zerres K. Increased risk for abnormal placentation in women affected by myotonic dystrophy. J Perinat Med. 1998;26:192-5.

Schlegel U. Malignant glioma: who benefits from therapy? Ann Neurol. 1999;45:824.

Schlegel U, Klockgether T. Primäre ZNS Lymphome: Chemotherapie mit Strahlentherapie erfolgreicher? Dtsch Arztebl. 1999;96:B-1477.

Schlegel U, Pels H, Glasmacher A, Kleinschmidt R, Bode U. Kombinierte Hochdosis-Polychemotherapie als effiziente alleinige Behandlung primär cerebraler Lymphome. Akt Neurol. 1998;25:297-303.

Schlegel U, Pels H, Oehring R, Blümcke I. Neurologic sequelae of treatment of primary CNS lymphomas. J Neurooncol. 1999;43:277-86.

Schmidt S. Candidate autoantigens in Multiple Sclerosis. Mult Scler. 1999;5:147-60.

Schmidt S. S100B: Pathogenetische und pathophysiologische Bedeutung in der Neurologie. Nervenarzt. 1998;69:639-46.

Schmidt S, Hertfelder HJ, von Spiegel T, Hering R, Harzheim M, Lassmann H, Deckert-Schlüter M, Schlegel U. Lethal capillary leak syndrome following a single administration of interferon beta-1b. Neurology. 1999;53:220-2.

Schmidt S, Padberg F. Late onset immunodeficiency in a patient with recurrent thymic carcinoma and myasthenia gravis. J Neurol Sci. 1998;157:201-5.

Schmidt T, Landwehrmeyer GB, Schmitt I, Trottier Y, Auburger G, Laccone F, Klockgether T, Völpel M, Epplen JT, Schöls L, Riess O. An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients. Brain Pathol. 1998;8:669-79.

Schröder R, Keller E, Flacke S, Schmidt S, Pohl C, Klockgether T, Schlegel U. MRI findings in Hirayama's disease: flexion induced cervical myelopathy or intrinsic motor neuron disease. J Neurol. 1999;246:1069-74.

Schröder R, Knoblich R, Rolfs A et al. Epidermolysis bullosa simplex mit Muskeldystrophie: eine Plectin-Defizienz bedingte Multisystemerkrankung. Nervenheilkunde. 1999;18:17-8.

Schröder R, Warlo I, Herrmann H van der Ven PF, Klasen C, Blümcke I, Mundegar RR, Fürst DO, Goebel HH, Magin TM. Immunogold EM reveals a close association of plectin and the desmin cytoskeleton in human skeletal muscle. Eur J Cell Biol. 1999;78:288-95.

Seyfried J, Soldner F, Schulz JB, Klockgether T, Kovar KA, Wüllner U. Differential effects of L-buthionine sulfoximine and etacrynic acid on glutathione levels and mitochondrial function. Neurosci Lett. 1999;264:1-4.

Sieb JP. Diagnose und Therapie kongenitaler Myasthenie-Syndrome. Dtsch Med Wochenschr. 1999;124:24-9.

Sieb JP. Effects of the fluoroquinoline antibiotics norfloxacin, ofloxacin, and pefloxacin on neuromuscular transmission. Neurology. 1998;50:804-7.

Sieb JP. Die Erkrankungen der motorischen Endplatte. Med Klinik. 1999;50:198-204.

Sieb JP. Rote Liste: unzureichende Warnhinweise für die Pharmakotherapie bei Myasthenia gravis. Z Allg Med. 1998;74:907-10.

Sieb JP, Dörfler P, Tzartos S, Wewer UM, Rüegg MA, Meyer D, Baumann I, Lindemuth R, Jakschik J, Ries F. Congenital myasthenic syndromes in two kinships with endplate acetylcholine receptor and utrophin deficiency. Neurology. 1998;50:54-61.

Soldner F, Weller M, Haid S, Beinroth S, Miller SW, Wüllner U, Davis RE, Dichgans J, Klockgether T, Schulz JB. MPP+ inhibits proliferation of PC12 cells by a p21(WAF1/Cip1)-dependent pathway and induces cell death in cells lacking p21(WAF1/Cip1). Exp Cell Res. 1999;250:75-85.

Tiemann K, Lohmeier S, Kuntz S, Köster J, Pohl C, Burns PN, Porter TR, Nanda NC, Lüderitz B, Becher H. Real-time contrast echo assessment of myocardial perfusion at low emission power: first experimental and clinical results using Power Pulse Inversion Imaging. Echocardiography. 1999;16:799-809.

Urbach H, Klisch J, Brechtelsbauer D, Gass S, Wolf HK, Solymosi L. MRI in sporadic Creutzfeldt-Jacob disease: Correlation with clinical and neuropathological data. Neuroradiology. 1998;40:65-70.

Wüllner U, Evert B, Klockgether T. Mechanisms of cell death in cerebellar disease. Restor Neurol Neurosci. 1998;13:69-73.

Wüllner U, Kornhuber J, Weller M, Schulz JB, Löschmann PA, Riederer P, Klockgether T. Cell death and apoptosis regulating proteins in Parkinson's Disease - a cautionary note. Acta Neuropathol. 1999;97:408-12.

Wüllner U, Seyfried J, Groscurth P, Beinroth S, Winter S, Gleichmann M, Heneka MT, Löschmann PA, Schulz JB, Weller M, Klockgether T. Glutathione depletion and neuronal cell death: the role of reactive oxygen species and mitochondrial function. Brain Res. 1999;826:53-62.